Dimitrios Makrakis

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

PloS one

BJU international

Cancers

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Konstantinos Rounis, Dimitrios Makrakis, Ioannis Gioulbasanis, Simon Ekman, Luigi De Petris, Dimitris Mavroudis, Sofia Agelaki
Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies. Life (Basel, Switzerland) 12 (6) (2022)
Dimitrios Makrakis, Sarah K Holt, Charles Bernick, Petros Grivas, John L Gore, Jonathan L Wright
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset. Alzheimer disease and associated disorders 36 (4) (2022)
Dimitrios Makrakis, Rafee Talukder, Leonidas N Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Ivan De Kouchkovsky, Vadim S Koshkin, Joseph J Park, Ajjai Alva, Mehmet A Bilen, Tyler F Stewart, Rana R McKay, Victor S Santos, Neeraj Agarwal, Jayanshu Jain, Yousef Zakharia, Rafael Morales-Barrera, Michael E Devitt, Michael Grant, Mark P Lythgoe, David J Pinato, Ariel Nelson, Christopher J Hoimes, Evan Shreck, Benjamin A Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Jure Murgic, Ana Fröbe, Alejo Rodriguez-Vida, Alexandra Drakaki, Sandy Liu, Vivek Kumar, Giuseppe Di Lorenzo, Monika Joshi, Pedro Isaacsson-Velho, Lucia Alonso Buznego, Ignacio Duran, Marcus Moses, Pedro Barata, Guru Sonpavde, Evan Y Yu, Jonathan L Wright, Petros Grivas, Ali Raza Khaki
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer. BJU international (2021)
Marcus Skribek, Konstantinos Rounis, Dimitrios Makrakis, Sofia Agelaki, Dimitris Mavroudis, Luigi De Petris, Simon Ekman, Georgios Tsakonas
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting. Cancers 12 (12) (2020)

Dimitrios Makrakis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dimitrios Makrakis